Science-as-a-service using human heart-muscle organoids and advanced processes to produce highly reproducible, high-detail preclinical cardiac data (e.g., drug testing). Serves biotech, pharmaceutical and academic researchers to accelerate development, de-risk preclinical stages and reduce animal testing.